Glenmede Trust’s 1Life Healthcare ONEM Stock Holding History

Glenmede Trust’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,574	Closed	-$498K	–	2426
2020 Q3	$498K	Buy	+17,574	New	+$555K	﹤0.01%	785

Other funds holding ONEM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Glenmede Trust's ONEM Position: Q4 2020 in Review

Glenmede Trust sold out of 1Life Healthcare (ONEM) in Q4 2020, closing a stake of 17,574 shares — an estimated $498K sold.

Glenmede Trust first reported a position in ONEM in Q3 2020 and held it in 1 quarter. The position peaked at $498K in Q3 2020. 235 funds tracked by Wall St. Rank hold ONEM as of Q4 2020.

Glenmede Trust reported no remaining 1Life Healthcare position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 17,574 1Life Healthcare shares in Q4 2020, an estimated $498K.
Glenmede Trust first reported a position in 1Life Healthcare in Q3 2020 and held it in 1 quarter.
Glenmede Trust's 1Life Healthcare position peaked at $498K in Q3 2020.
235 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.